AU2015223579B2 - Aminocarbonylcarbamate compounds - Google Patents
Aminocarbonylcarbamate compounds Download PDFInfo
- Publication number
- AU2015223579B2 AU2015223579B2 AU2015223579A AU2015223579A AU2015223579B2 AU 2015223579 B2 AU2015223579 B2 AU 2015223579B2 AU 2015223579 A AU2015223579 A AU 2015223579A AU 2015223579 A AU2015223579 A AU 2015223579A AU 2015223579 B2 AU2015223579 B2 AU 2015223579B2
- Authority
- AU
- Australia
- Prior art keywords
- aminocarbonyl
- amino
- propyl
- methylcarbamate
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 C*C(*)N[C@](Cc1ccccc1)COC(NC(N=I)=O)=O Chemical compound C*C(*)N[C@](Cc1ccccc1)COC(NC(N=I)=O)=O 0.000 description 2
- AIEXYFOIKCDMSR-GFCCVEGCSA-N C=C(N)N(CI)C(OC[C@@H](Cc(cc1)cc(Cl)c1Cl)N)=C Chemical compound C=C(N)N(CI)C(OC[C@@H](Cc(cc1)cc(Cl)c1Cl)N)=C AIEXYFOIKCDMSR-GFCCVEGCSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/58—Y being a hetero atom
- C07C275/60—Y being an oxygen atom, e.g. allophanic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019236666A AU2019236666B2 (en) | 2014-02-28 | 2019-09-25 | Aminocarbonylcarbamate compounds |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461946142P | 2014-02-28 | 2014-02-28 | |
| US61/946,142 | 2014-02-28 | ||
| PCT/KR2015/001915 WO2015130121A1 (en) | 2014-02-28 | 2015-02-27 | Aminocarbonylcarbamate compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019236666A Division AU2019236666B2 (en) | 2014-02-28 | 2019-09-25 | Aminocarbonylcarbamate compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2015223579A1 AU2015223579A1 (en) | 2016-08-25 |
| AU2015223579B2 true AU2015223579B2 (en) | 2019-06-27 |
Family
ID=54006446
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015223579A Active AU2015223579B2 (en) | 2014-02-28 | 2015-02-27 | Aminocarbonylcarbamate compounds |
| AU2019236666A Active AU2019236666B2 (en) | 2014-02-28 | 2019-09-25 | Aminocarbonylcarbamate compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019236666A Active AU2019236666B2 (en) | 2014-02-28 | 2019-09-25 | Aminocarbonylcarbamate compounds |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US9403761B2 (enExample) |
| EP (2) | EP3587394B1 (enExample) |
| JP (2) | JP6452731B2 (enExample) |
| KR (2) | KR102487051B1 (enExample) |
| CN (2) | CN109627186B (enExample) |
| AR (1) | AR099581A1 (enExample) |
| AU (2) | AU2015223579B2 (enExample) |
| CA (1) | CA2939835C (enExample) |
| CL (1) | CL2016002165A1 (enExample) |
| ES (2) | ES2759312T3 (enExample) |
| MX (2) | MX2016010973A (enExample) |
| PL (1) | PL3110792T3 (enExample) |
| RU (1) | RU2688673C2 (enExample) |
| TW (2) | TWI655179B (enExample) |
| WO (1) | WO2015130121A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI655179B (zh) * | 2014-02-28 | 2019-04-01 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
| US10888542B2 (en) * | 2014-02-28 | 2021-01-12 | Sk Biopharmaceuticals Co., Ltd. | Aminocarbonylcarbamate compounds |
| CN121202730A (zh) * | 2016-09-06 | 2025-12-26 | 爱尔兰贾兹制药有限公司 | (r)-2-氨基-3-苯丙基氨基甲酸酯盐酸盐的制备方法、其组合物及用途 |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| JP7074750B2 (ja) | 2016-10-06 | 2022-05-24 | ジャズ ファーマスティカルズ アイルランド リミテッド | カルバモイルフェニルアラニノール化合物およびその使用 |
| KR20200016889A (ko) | 2017-06-02 | 2020-02-17 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 과다 졸림증을 치료하기 위한 방법 및 조성물 |
| CN111153863A (zh) * | 2019-12-13 | 2020-05-15 | 浙江工业大学 | 一种合成动物用抗球虫药物妥曲珠利的方法 |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
| KR102390194B1 (ko) | 2020-08-03 | 2022-04-25 | 셀라이온바이오메드 주식회사 | 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102695502A (zh) * | 2009-06-26 | 2012-09-26 | 爱思开生物制药株式会社 | 用于治疗药瘾和改善药瘾相关行为的组合物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5077289A (en) * | 1989-11-30 | 1991-12-31 | Hoechst Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
| CA2146755A1 (en) * | 1992-10-28 | 1994-05-11 | Kenji Takeda | Novel 1,2-benzoisoxazole derivative or its salt and brain-protecting agent comprising the same |
| KR100197892B1 (ko) * | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
| US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
| KR0173862B1 (ko) * | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| KR0173863B1 (ko) | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| JP2006527214A (ja) * | 2003-06-12 | 2006-11-30 | ノボ ノルディスク アクティーゼルスカブ | パラ置換されたフェニルカルバメート |
| US20050080268A1 (en) | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
| US7897639B2 (en) * | 2003-10-21 | 2011-03-01 | Colucid Pharmaceuticals, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| RU2007119648A (ru) | 2004-10-28 | 2008-12-10 | СК Холдингз Ко. | Способ лечения депрессии |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| PL1890684T3 (pl) * | 2005-06-08 | 2014-05-30 | Sk Biopharmaceuticals Co Ltd | Leczenie zaburzeń snu i czuwania |
| US8552060B2 (en) | 2005-06-22 | 2013-10-08 | Sk Biopharmaceuticals Co., Ltd. | Methods for treatment of sexual dysfunction |
| TW200820963A (en) * | 2006-07-28 | 2008-05-16 | Xenoport Inc | Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use |
| CN101631770A (zh) * | 2007-02-02 | 2010-01-20 | 科露西德医药品公司 | 抑制胆碱酯酶的化合物 |
| AU2010270971B2 (en) | 2009-06-22 | 2015-08-20 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating or preventing fatigue |
| EP2496227B1 (en) | 2009-11-06 | 2019-05-22 | SK Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
| ES2447295T3 (es) * | 2009-11-06 | 2014-03-11 | Sk Biopharmaceuticals Co., Ltd. | Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad |
| US9610274B2 (en) * | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8623913B2 (en) * | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| DK3021838T3 (da) * | 2013-07-18 | 2020-08-24 | Jazz Pharmaceuticals Ireland Ltd | Behandling af fedme |
| TWI655179B (zh) * | 2014-02-28 | 2019-04-01 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
-
2015
- 2015-02-25 TW TW104106005A patent/TWI655179B/zh not_active IP Right Cessation
- 2015-02-25 TW TW108106172A patent/TWI698415B/zh not_active IP Right Cessation
- 2015-02-26 AR ARP150100575A patent/AR099581A1/es active IP Right Grant
- 2015-02-27 ES ES15754658T patent/ES2759312T3/es active Active
- 2015-02-27 JP JP2016572221A patent/JP6452731B2/ja active Active
- 2015-02-27 US US14/633,388 patent/US9403761B2/en active Active
- 2015-02-27 RU RU2016136193A patent/RU2688673C2/ru active
- 2015-02-27 MX MX2016010973A patent/MX2016010973A/es active IP Right Grant
- 2015-02-27 CN CN201811495363.1A patent/CN109627186B/zh active Active
- 2015-02-27 KR KR1020217031464A patent/KR102487051B1/ko active Active
- 2015-02-27 CN CN201580010772.6A patent/CN106458866B/zh active Active
- 2015-02-27 EP EP19188405.5A patent/EP3587394B1/en active Active
- 2015-02-27 AU AU2015223579A patent/AU2015223579B2/en active Active
- 2015-02-27 ES ES19188405T patent/ES2968840T3/es active Active
- 2015-02-27 WO PCT/KR2015/001915 patent/WO2015130121A1/en not_active Ceased
- 2015-02-27 CA CA2939835A patent/CA2939835C/en active Active
- 2015-02-27 KR KR1020167022646A patent/KR102309903B1/ko active Active
- 2015-02-27 EP EP15754658.1A patent/EP3110792B1/en active Active
- 2015-02-27 PL PL15754658T patent/PL3110792T3/pl unknown
- 2015-02-27 MX MX2020003020A patent/MX387796B/es unknown
-
2016
- 2016-06-28 US US15/195,326 patent/US9833432B2/en active Active
- 2016-08-26 CL CL2016002165A patent/CL2016002165A1/es unknown
-
2017
- 2017-11-07 US US15/805,293 patent/US10314808B2/en active Active
-
2018
- 2018-12-11 JP JP2018231320A patent/JP6595078B2/ja active Active
-
2019
- 2019-04-26 US US16/395,422 patent/US10485781B2/en active Active
- 2019-09-25 AU AU2019236666A patent/AU2019236666B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102695502A (zh) * | 2009-06-26 | 2012-09-26 | 爱思开生物制药株式会社 | 用于治疗药瘾和改善药瘾相关行为的组合物 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019236666B2 (en) | Aminocarbonylcarbamate compounds | |
| JP6677739B2 (ja) | ビグアニド化合物及びその使用 | |
| US20230218562A1 (en) | Aminocarbonylcarbamate compounds | |
| MX2007015689A (es) | Nuevos derivados de 2-(fenilamino)bencimidazol y su uso como moduladores de los canales de potasio activados por calcio de pequena conductancia. | |
| RU2790360C2 (ru) | Аминокарбонилкарбаматные соединения | |
| HK40007355A (en) | Aminocarbonylcarbamate compounds | |
| HK40007355B (en) | Aminocarbonylcarbamate compounds | |
| HK1233615A1 (en) | Aminocarbonylcarbamate compounds | |
| HK1233615B (en) | Aminocarbonylcarbamate compounds | |
| BR112016019737B1 (pt) | Composto, e, composição farmacêutica | |
| EP4582412A1 (en) | Chiral gamma lactam derivative or pharmaceutically acceptable salt thereof, and preparation method therefor | |
| JP2008239546A (ja) | アミノアルコール誘導体及びそれらを有効成分とする免疫抑制剤 | |
| JP2010530900A (ja) | 中枢神経系活性を有する置換ピロリジン化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |